Bristol-Myers Squibb   4Q Revenues: $5.4 billion (+33%) 4Q Loss: $89 million (loss of $134 million in 4Q2006) FY Revenues: $19.3 billion (+12%) FY Earnings: $2.2 billion (+37%) Comments: Worldwide pharmaceutical sales increased 39% to $4.4 billion in the quarter. U.S. pharma sales were up 65% to $2.5 billion due to increased Plavix sales, as well as growth of Abilify, Reyataz, the Sustiva Franchise and Erbitux, and sales of newer products Orencia, Baraclude, Sprycel and Ixempra. Pl...